Perspective Therapeutics (CATX)

• Market cap: $166M
• 1 day: -1.79%
• 5 days: -20.94%
• 1 month: -36.89%
• 3 months: -39.67%
• 6 months: -6.81%
• Year to date: -33.84%
• 1 year: -81.41%
• 5 years: -47.86%
• 10 years: -84.79%
• Sector: Healthcare
• Industry: Medical Instruments & Supplies

About: Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.

Employees: 140